Xenon Pharmaceuticals Inc
Market Cap
5.1B
Short interest (May 15)
4.0%
Net Short (Jun 03 ): -0.3%
Borrow Fee
0.41%
↑ 26.7%
Available Shares
2M
↑ 30.0%
Price Chart
Company Overview
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.